Purpose
to plan to evaluate safety and immunogenicity of novel OPV2 when co-administered with bOPV in infants in a randomized control trial
Grantee
Division
Global Development
Date
SEPTEMBER 2020
Region served
GLOBAL
Committed amount
$183,692
Grant topic
Polio
Duration (months)
17
Grantee location
Coral Gables, Florida, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.